//
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
AIM2-driven inflammasome activation in heart failure
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry
Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients